Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H37NO4 |
Molecular Weight | 415.5656 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC2=CC=CC=C2
InChI
InChIKey=AQOKCDNYWBIDND-FTOWTWDKSA-N
InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1
Molecular Formula | C25H37NO4 |
Molecular Weight | 415.5656 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:12 UTC 2023
by
admin
on
Fri Dec 15 15:45:12 UTC 2023
|
Record UNII |
QXS94885MZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
WHO-ATC |
S01EE03
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
NCI_THESAURUS |
C29705
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
WHO-VATC |
QS01EE03
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LUMIGAN (AUTHORIZED: GLAUCOMA, OPEN-ANGLE)
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
GANFORT (AUTHORIZED: OCULAR HYPERTENSION0
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
BIMATOPROST (AUTHORIZED: OCULAR HYPERTENSION)
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
LUMIGAN (AUTHORIZED: OCULAR HYPERTENSION)
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
||
|
NDF-RT |
N0000175454
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8035
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
BIMATOPROST
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
QXS94885MZ
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
100000089302
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
Bimatoprost
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
SUB12470MIG
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
1958
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
5311027
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
QXS94885MZ
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
CHEMBL1200963
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
DTXSID30895042
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
51230
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
C47414
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
155206-00-1
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
LL-78
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
DB00905
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
371
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
C420823
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | |||
|
283810
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | RxNorm | ||
|
m2495
Created by
admin on Fri Dec 15 15:45:12 UTC 2023 , Edited by admin on Fri Dec 15 15:45:12 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST | |||
|
TARGET -> AGONIST | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||